CHINA GRAPHITE (02237): He Kaidong has been appointed as an independent non-executive director.
China Graphite (02237) announced that Zhao Zhiqiao has resigned as an independent non-executive director due to devoting more time to other personal affairs.
CHINA GRAPHITE (02237) announcement: Zhao Zhiqiao has resigned as an independent non-executive director due to devoting more time to personal affairs. He will no longer serve as the chairman of the board's audit committee, a member of the board's nomination committee, a member of the board's remuneration committee, and a member of the board's compliance committee, effective September 24, 2024. After ceasing his directorship and duties on the board, Zhao Zhiqiao will no longer hold any other positions within the group.
He Kaidong has been appointed as an independent non-executive director, chairman of the audit committee, and a member of the compliance committee, effective September 24, 2024.
Related Articles

HK Stock Market Move | Q TECH (01478) rose more than 3%, planning to sell 51.08% stake in Indian Qutai for 5.53 billion Indian rupees.

HK Stock Market Move | Chip stocks continue to be strong in the near term. Alibaba and Baidu have developed their own AI chips. Domestic model training is gradually decoupling from overseas.

HK Stock Market Move | BIOCYTOGEN-B(02315) rose by over 15% in the morning session, and its initial public offering on the Sci-Tech Innovation Board is coming up. The company reached an agreement with Merck at the beginning of the month for antibody authorization cooperation.
HK Stock Market Move | Q TECH (01478) rose more than 3%, planning to sell 51.08% stake in Indian Qutai for 5.53 billion Indian rupees.

HK Stock Market Move | Chip stocks continue to be strong in the near term. Alibaba and Baidu have developed their own AI chips. Domestic model training is gradually decoupling from overseas.

HK Stock Market Move | BIOCYTOGEN-B(02315) rose by over 15% in the morning session, and its initial public offering on the Sci-Tech Innovation Board is coming up. The company reached an agreement with Merck at the beginning of the month for antibody authorization cooperation.
